|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Mouse ATL1 ORF mammalian expression plasmid, C-GFPSpark tag||MG50784-ACG|
|Mouse ATL1 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||MG50784-ACR|
|Mouse ATL1 ORF mammalian expression plasmid, C-Flag tag||MG50784-CF|
|Mouse ATL1 ORF mammalian expression plasmid, C-His tag||MG50784-CH|
|Mouse ATL1 ORF mammalian expression plasmid, C-Myc tag||MG50784-CM|
|Mouse ATL1 ORF mammalian expression plasmid, C-HA tag||MG50784-CY|
|Mouse ATL1 Gene cDNA clone plasmid||MG50784-G|
|Mouse ATL1 ORF mammalian expression plasmid, N-Flag tag||MG50784-NF|
|Mouse ATL1 ORF mammalian expression plasmid, N-His tag||MG50784-NH|
|Mouse ATL1 ORF mammalian expression plasmid, N-Myc tag||MG50784-NM|
|Mouse ATL1 ORF mammalian expression plasmid, N-HA tag||MG50784-NY|
|Mouse ATL1 natural ORF mammalian expression plasmid||MG50784-UT|
|Узнайте больше о векторов экспрессии,|
Atlastin-1, also known as Spastic paraplegia 3 protein A, Guanine nucleotide-binding protein 3, GTP-binding protein 3, GBP3, ATL1 and SPG3A, is a multi-pass membrane protein which belongs to the GBP family and atlastin subfamily. ATL1 / SPG3A is expressed predominantly in the adult and fetal central nervous system. Expression of ATL1 / SPG3A in adult brain is at least 50-fold higher than in other tissues. ATL1 / SPG3A is detected predominantly in pyramidal neurons in the cerebral cortex and the hippocampus of the brain. ATL1 / SPG3A is also expressed in upper and lower motor neurons (at protein level). A distinguishing feature of ATL1 / SPG3A is its frequent early onset, raising the possibility that developmental abnormalities may be involved in its pathogenesis. Missense SPG3A mutant atlastin-1 proteins have impaired GTPase activity and may act in a dominant-negative, loss-of-function manner by forming mixed oligomers with wild-type atlastin-1. Defects in ATL1 / SPG3A are the cause of spastic paraplegia autosomal dominant type 3 (SPG3), also known as Strumpell-Lorrain syndrome. Spastic paraplegia is a degenerative spinal cord disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs.